
|Podcasts|March 4, 2021
Podcast: Find out more about Allergan’s presbyopia drop NDA filing
Potential presbyopia treatment coming
Advertisement
Learn more about the recent new drug application (NDA) Allergan submitted for its investigational eyedrop to treat presbyopia. Optometry Times® Editor in Chief Gretchyn Bailey, NCLC, FAAO, chats with Michael Robinson, MD, vice president, global therapeutic area head of ophthalmology at Allergan, to get details on when ODs could discuss a potential presbyopia treatment with their patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
The changing IPL landscape: How advances in light-based technology are reshaping the treatment of MGD
2
Study: Tryptyr treatment associated with complex visual tasks improvement in DED patients
3
Survey: Fewer than 1 in 7 women link dry eye to perimenopause or menopause
4
DOT spectacle lens wear count ascends to 2 million pairs worldwide
5














